Comparison
5p Partial Monosomy Syndrome C0010314 vs 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
Clinical comparison between 5P Partial Monosomy Syndrome and 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete CN042980 for differential diagnosis and treatment planning.
5p Partial Monosomy Syndrome C0010314
Also called Cri-du-chat syndrome, caused by a deletion on chromosome 5. Features include a high-pitched cry, developmental delay, and intellectual disability.
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
A rare enzyme deficiency affecting hormone production, leading to low sex hormones and elevated blood pressure. Lifelong hormone replacement therapy is typically needed. Ongoing medical monitoring helps manage associated health concerns.
6 comparison axes
Onset
5p Partial Monosomy Syndrome C0010314
0-0
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
0-null
Onset patterns differ
Severity
5p Partial Monosomy Syndrome C0010314
severe
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
severe
Different severity levels
Chronic
5p Partial Monosomy Syndrome C0010314
Chronic
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
Chronic
Differing course
Communicable
5p Partial Monosomy Syndrome C0010314
No
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
No
Different transmission
Body System
5p Partial Monosomy Syndrome C0010314
congenital
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
endocrine
Same/different system
Category
5p Partial Monosomy Syndrome C0010314
genetic
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
endocrine
Different category
Bottom line
5p-partial-monosomy-syndrome-C0010314 and 17-alpha-hydroxylase-17-20-lyase-deficiency-combined-complete-CN042980 differ in etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 5p Partial Monosomy Syndrome C0010314 | 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980 | Discriminating power |
|---|---|---|---|
| Infant cry | High-pitched cry is a characteristic described feature. | No characteristic cry is established. | High |
| Development | Developmental delay and intellectual disability are described. | Primary features concern hormones and blood pressure, not established developmental delay. | High |
| Blood pressure and puberty | Hypertension or sex-hormone deficiency is not a defining feature. | Low sex hormones and elevated blood pressure are described. | High |
When to favor each condition
Choose 5p Partial Monosomy Syndrome C0010314 when
Congenital features with a high-pitched cry
This pattern aligns with the supplied chromosomal description.
Moderate
Suspected genetic developmental disorder
Chromosomal testing is more relevant than endocrine enzyme testing.
Moderate
No endocrine phenotype
Absence of hormone or blood-pressure features favors the congenital condition.
Low
Choose 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980 when
Hypertension with low sex hormones
This combination matches the supplied enzyme-deficiency description.
Moderate
Need for hormone replacement
Lifelong replacement is typically described for this deficiency.
Moderate
Normal chromosomal evaluation
An endocrine cause becomes more plausible, but confirmation is required.
Low
How key tests differ
| Test | 5p Partial Monosomy Syndrome C0010314 | 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980 | Interpretation |
|---|---|---|---|
| Chromosomal analysis | Deletion involving chromosome 5 may be identified. | No chromosome 5 deletion is expected from the description. | A genetic result supports the left condition but needs specialist review. |
| Blood pressure assessment | No characteristic elevation is established. | Elevated blood pressure is a described feature. | An abnormal reading is not itself a diagnosis. |
| Sex-hormone evaluation | No characteristic deficiency is established. | Low sex hormones are described. | Results require endocrine interpretation; exact cutoffs are not supplied. |
Prognosis comparison
5p Partial Monosomy Syndrome C0010314
- Outcome
- A chronic congenital condition with developmental effects; exact outcomes are not established here.
- Factors
- Extent of the deletion and available developmental support may influence needs.
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
- Outcome
- A chronic endocrine condition typically requiring lifelong hormone replacement and monitoring.
- Factors
- Blood-pressure control, hormone management, and adherence may affect health.
Time frame: Both are described as chronic; no reliable timeline is supplied.
Individual findings, specialist care, and associated health concerns determine management.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental impairment | Delay and intellectual disability are described. Not established by the supplied description. Support needs should be individualized. |
| Hypertension-related concerns | Not a defining feature. Elevated blood pressure requires monitoring. Specific complication rates are not established here. |
| Sex-hormone deficiency effects | Not established as characteristic. Low sex hormones and replacement needs are described. Clinical effects vary and need specialist assessment. |
Patient education highlights
- HighDifferent causes
One is a chromosomal condition; the other is a rare hormone-production disorder.
- HighSpecialist follow-up
Genetics or endocrinology follow-up should guide testing and treatment decisions.
- MediumMonitoring
Development, blood pressure, and hormone status may need ongoing review as clinically indicated.